Works by Migkou, Magdalini

Results: 94
    1

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    2

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    3

    Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 763, doi. 10.3390/cancers13040763
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Markellos, Christos;
    • Migkou, Magdalini;
    • Eleftherakis-Papaiakovou, Evangelos;
    • Koutsoukos, Konstantinos;
    • Gavriatopoulou, Maria;
    • Zagouri, Flora;
    • Psaltopoulou, Theodora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • D'Orazi, Gabriella;
    • Cirone, Mara
    Publication type:
    Article
    4

    The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00530-3
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    5

    Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00381-4
    By:
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Dialoupi, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Giannouli, Stavroula;
    • Delavinia, Christina;
    • Efstathiou, Kostantinos;
    • Kontogiannis, Sofoklis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    6

    The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41408-020-00360-9
    By:
    • Gavriatopoulou, Maria;
    • Βoultadaki, Andriani;
    • Koutoulidis, Vassilis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Bourgioti, Charis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Moulopoulos, Lia-Angela
    Publication type:
    Article
    7

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    8

    Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331
    By:
    • Dimopoulos, Meletios A.;
    • Migkou, Magdalini;
    • Bhutani, Manisha;
    • Ailawadhi, Sikander;
    • Kalff, Anna;
    • Walcott, Farzana L.;
    • Pore, Nabendu;
    • Brown, Miranda;
    • Wang, Fujun;
    • Cheng, Lily I.;
    • Kagiampakis, Ioannis;
    • Williams, Marna;
    • Kinneer, Krista;
    • Wu, Yuling;
    • Jiang, Yu;
    • Kubiak, Robert J.;
    • Zonder, Jeffrey A.;
    • Larsen, Jeremy;
    • Sirdesai, Shreerang;
    • Yee, Andrew J.
    Publication type:
    Article
    9

    Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 13, p. 2140, doi. 10.1080/10428194.2023.2253479
    By:
    • Eleutherakis Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despoina;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kostopoulos, Ioannis V.;
    • Tsitsiloni, Ourania;
    • Tsirigotis, Panagiotis;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    10

    Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 6, p. 1212, doi. 10.1080/10428194.2023.2197537
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    11
    12
    13

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 3, p. 619, doi. 10.1080/10428194.2018.1509323
    By:
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Koloventzou, Ursula;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Gika, Dimitra;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    14

    Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.

    Published in:
    2018
    By:
    • Ziogas, Dimitrios C.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Fotiou, Despoina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Tatouli, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Case Study
    15
    16

    Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 8, p. 1832, doi. 10.1080/10428194.2016.1267349
    By:
    • Ziogas, Dimitrios C.;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Spanomichou, Despoina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despoina;
    • Panagiotidis, Ioannis;
    • Kafantari, Eftychia;
    • Psimenou, Erasmia;
    • Boletis, Ioannis;
    • Vlahakos, Demetrios V.;
    • Gakiopoulou, Hariklia;
    • Matsouka, Charis;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    17
    18
    19

    Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1887, doi. 10.1002/ajh.27414
    By:
    • Kostopoulos, Ioannis V.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Rousakis, Pantelis;
    • Malandrakis, Panagiotis;
    • Panteli, Chrysanthi;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Angelis, Nikolaos;
    • Spiliopoulou, Vasiliki;
    • Syrigou, Rodanthi‐Eleni;
    • Bakouros, Panagiotis;
    • Dimitrakopoulou, Georgia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Paschalidis, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    20

    Belantamab mafodotin, lenalidomide, and dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin‐associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 502, doi. 10.1002/ajh.27219
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Psarros, Giorgos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    21

    Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 396, doi. 10.1002/ajh.27206
    By:
    • Terpos, Evangelos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Katodritou, Eirini;
    • Hatjiharissi, Evdoxia;
    • Malandrakis, Panagiotis;
    • Verrou, Evgenia;
    • Golfinopoulos, Stavros;
    • Migkou, Magdalini;
    • Manousou, Kyriaki;
    • Delimpasi, Sosana;
    • Symeonidis, Argiris;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    22

    Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E226, doi. 10.1002/ajh.27001
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Symeonidis, Argiris;
    • Labropoulou, Vasiliki;
    • Delimpasi, Sosana;
    • Mancuso, Katia;
    • Zamagni, Elena;
    • Katodritou, Eirini;
    • Rivolti, Elena;
    • Kyrtsonis, Marie‐Christine;
    • Roussou, Maria;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Hatjiharissi, Evdoxia;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Cheliotis, Giorgos;
    • Manousou, Kyriaki;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    23

    Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1142, doi. 10.1002/ajh.26639
    By:
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Dalampira, Dimitra;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Sevastoudi, Aggeliki;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Triantafyllou, Theodora;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    24

    Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. E27, doi. 10.1002/ajh.26406
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Evangelakou, Zoi;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Manola, Maria S.;
    • Gianniou, Despoina D.;
    • Bagratuni, Tina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    25

    Cell‐free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. E148, doi. 10.1002/ajh.25802
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Bagratuni, Tina;
    • Gavriatopoulou, Maria;
    • Patseas, Dimitrios;
    • Liacos, Christine;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Tsiligkeridou, Eleni;
    • Andreatou, Amalia;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    26

    Bone marrow biopsy in low‐risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 5, p. E146, doi. 10.1002/ajh.25441
    By:
    • Bustoros, Mark;
    • Kastritis, Efstathios;
    • Sklavenitis‐Pistofidis, Romanos;
    • Liu, Chia‐Jen;
    • Hornburg, Kalvis;
    • Kanellias, Nikolaos;
    • Kim, Geon;
    • Liu, David;
    • Gavriatopoulou, Maria;
    • Marinac, Catherine R.;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Noonan, Kimberly;
    • Reyes, Kaitlen;
    • Rivotto, Bradley;
    • Neuse, Carl Jannes;
    • Ziogas, Dimitrios C.;
    • Laubach, Jacob;
    • Terpos, Evangelos;
    • Anderson, Kenneth C.
    Publication type:
    Article
    27

    Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 4, p. 400, doi. 10.1002/ajh.25392
    By:
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Papatheodorou, Athanasios;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Trougakos, Ioannis P.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    28

    Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 7, p. 632, doi. 10.1002/ajh.24738
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C;
    • Kanellias, Nikos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Giannouli, Stavroula;
    • Psimenou, Erasmia;
    • Marinaki, Smaragdi;
    • Apostolou, Theofanis;
    • Gakiopoulou, Hariklia;
    • Tasidou, Anna;
    • Papassotiriou, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    29

    Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 5, p. 499, doi. 10.1002/ajh.24335
    By:
    • Dimopoulos, Meletios A.;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Gika, Dimitra;
    • Kafantari, Eftychia;
    • Ziogas, Dimitrios;
    • Fotiou, Despoina;
    • Panagiotidis, Ioannis;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    30

    Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. E60, doi. 10.1002/ajh.23936
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kalapanida, Despina;
    • Pamboucas, Constantinos;
    • Kaldara, Elisavet;
    • Ntalianis, Argyrios;
    • Psimenou, Erasmia;
    • Toumanidis, Savvas T.;
    • Tasidou, Anna;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    31

    Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 9, p. 861, doi. 10.1002/ajh.23258
    By:
    • Moulopoulos, Lia A.;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Christoulas, Dimitrios;
    • Gkotzamanidou, Maria;
    • Roussou, Maria;
    • Koureas, Andreas;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gika, Dimitra;
    • Koutoulidis, Vasilios;
    • Terpos, Evangelos
    Publication type:
    Article
    32

    Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 7, p. 734, doi. 10.1002/ajh.23223
    By:
    • Tasidou, Anna;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Gkotzamanidou, Maria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Nikitas, Nikitas;
    • Anagnostou, Dimitra;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    33

    Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 10, p. 882, doi. 10.1002/ajh.22135
    By:
    • Zagouri, Flora;
    • Roussou, Maria;
    • Kastritis, Efstathios;
    • Koureas, Andreas;
    • Tsokou, Eleni;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Nikitas, Nikitas;
    • Gkotzamanidou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    34

    Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
    By:
    • Kostopoulos, Ioannis V.;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Malandrakis, Panagiotis;
    • Migkou, Magdalini;
    • Angelis, Nikolaos;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Krevvata, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Kastritis, Efstathios
    Publication type:
    Article
    35

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    36

    Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 844, doi. 10.1016/j.clml.2023.07.013
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Solia, Eirini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Kokkali, Nikoleta;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Syrigou, Rodanthi;
    • Fotiou, Despina;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    37

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    38

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    39

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    40

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    41

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    42

    Flow-Mediated Dilatation (FMD) and Aortic Blood Pressure May Predict Cardiovascular Adverse Events During Carfilzomib Therapy: A Prospective Study in Relapsed/Refractory Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.433
    By:
    • Kastritis, Efstathios;
    • Laina, Aggeliki;
    • Gavriatopoulou, Maria;
    • Georgiopoulos, Georgios;
    • Fotiou, Despina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Makris, Nikolaos;
    • Papanota, Aristea-Maria;
    • Trougakos, Ioannis P.;
    • Kotsopoulou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    43

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    44

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    45

    Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S333, doi. 10.1016/j.clml.2019.07.325
    By:
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Moulopoulos, Lia A.;
    • Christoulas, Dimitrios;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Bagratuni, Tina;
    • Koutoulidis, Vasilios;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    46

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    47

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S325, doi. 10.1016/j.clml.2019.07.310
    By:
    • Papanota, Aristea-Maria;
    • Kastritis, Efstathios;
    • Papassotiriou, Gerasimos-Petros;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Margeli, Alexandra;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    48

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article
    49
    50

    Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
    By:
    • Dimopoulos, Meletios Athanasios;
    • Pouli, Anastasia;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Psimenou, Erasmia;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article